Cloning of m-calpain 80 kD subunit from the axonal degeneration- resistant WLD(S) mouse mutant

Journal of Neuroscience Research

Volumn 52, Issue 6, 1998, Pages 653-660

  Glass, Jonathan D ^a   Nash, Norman ^a   Dry, Ian ^b   Culver, Deborah ^a   Levey, Allan I ^a   Wesselingh, Steven ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CSIRO   (Australia)

^c FLINDERS UNIVERSITY   (Australia)

Author keywords

Calpain; Mouse; Neurodegeneration; Protease; Wallerian degeneration; WLD(S)

Indexed keywords

CALPAIN; CYSTEINE PROTEINASE; HYBRID PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ENZYME ACTIVATION; MOLECULAR CLONING; MOUSE; NERVE FIBER DEGENERATION; NERVE INJURY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMINO ACID SEQUENCE; ANIMALS; AXONS; BLOTTING, WESTERN; CALPAIN; CLONING, MOLECULAR; IMMUNITY, NATURAL; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MOLECULAR SEQUENCE DATA; NERVE DEGENERATION; PEPTIDE FRAGMENTS; REFERENCE VALUES; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; TISSUE DISTRIBUTION;

EID: 0032526379     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19980615)52:6<653::AID-JNR4>3.0.CO;2-7     Document Type: Article

References (38)

1. Banay-Schwartz M, DeGuzman T, Palkovits M, Lajtha A (1994): Calpain activity in adult and aged human brain regions. Neuroichem Res 19:563-567.
2. Bartus RT, Elliott PJ, Hayward NJ, Dean RL, Harbeson S, Straub JA, Li Z, Powers JC (1995): Calpain as a novel target for treating acute neurodegenerative disorders. Neurol Res 17:249-258.
3. Ciliax BJ, Heilman C, Edmunds S, Hersch SM, Levey AI (1995): Anti-fusion protein antibodies specific for receptor subtypes. In Conn PM, Sealfon SC (eds): "Receptor Molecular Biology," vol 25. Orlando: Academic Press, pp 431-454.
4. Croall DE, Slaughter CA, Wortham HS, Skelly CM, DeOgny L, Moomaw CR (1992): Polyclonal antisera specific for the proenzyme form of each calpain. Biochim Biophys Acta 1121(1-2):47-53.
5. Dear N, Matena K, Vingron M, Boehm T ( 1997): A new subfamily of vertebrate calpains lacking a calmodulin-like domain: Implications for calpain regulation and evolution. Genomics 45:175-184.
6. DeLuca CI, Davies PL, Samis JA, Elce JS (1993): Molecular cloning and bacterial expression of cDNA for rat calpain II 80 kDa subunit. Biochem Biophys Acta 1216(1):81-93.
7. George EB, Glass JD, Griffin JW (1995): Axotomy-induced axonal degeneration is mediated by calcium influx through ion-specific channels. J Neurosci 15(10): 6445-6452.
8. Glass JD, Brushart TM, George EB, Griffin JW (1993): Prolonged survival of transected nerve fibres in C57BL/Ola mice is an intrinsic characteristic of the axon. J Neurocytol 22(5):311-321.
9. Glass JD, Schryer BL, Griffin JW (1994): Calcium-mediated degeneration of the axonal cytoskeleton in the Ola mouse. J Neurochem 62(6):2472-2475.
10. Hamakubo T, Kannagi R, Murachi T, Matus A (1986): Distribution of calpains I and II in rat brain. J Neurosci 6(11):3103-3111.
11. Hong O, Chapman R, Kang C, Nixon R (1995): Overexpression of recombinant human calpastatin in E. coli and its neuroprotective effects against excitotoxicity. Soc Neurosci 21:608.
12. 2+-activated neutral protease in the peripheral nerve and its effects on neurofilament degeneration. J Neurochem 40:908-913.
13. Levey AI, Hersch SM, Rye DB, Sunahara RK, Niznik HB, Kitt CA, Price DL, Maggio R, Brann MR, Ciliax BJ (1993): Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies. Proc Nat Acad Sci USA 90(19):8861-8865.
14. Li J, Berman SA, Nixon R, Bursztain S (1993): Altered gene expression for calcium activated neutral protease (calpain) and its endogenous inhibitor (calpastatin) in the motor neuron degeneration (Mnd) mutant mouse. Soc Neurosci Abstacts 19(Prt 1): 835.
15. Li ZH, Hogan EL, Banik N (1995): Role of calpain in spinal cord injury-increased calpain immunoreactivity in spinal cord after compression injury in the rat. Neurochem Int 27:425-432.
16. Lunn ER, Perry VH, Brown MC, Rosen H, Gordon S (1989): Absence of Wallerian degeneration does not hinder regeneration in peripheral nerve. Eur J Nerosci 1:27-33.
17. Lyon MF, Ogunkolade BW, Brown MC, Atherton DJ, Perry VH (1993): A gene affecting Wallerian nerve degeneration maps distally on mouse chromosome 4. Proc Nat Acad Sci USA 90(20):9717-9720.
18. Marchuk D, Drumm M, Saulino A, Collins FS (1991): Construction of T-vectors, a rapid and general system for direct cloning of unmodified PCR products. Nucl Acids Res 19(5):1154.
19. Melloni E, Pontremoli S (1989): The calpains. Trends Neurosci 12:438-444.
20. Melloni E, Salamino F, Sparatore B (1992): The calpain-calpastatin system in mammalian cells: Properties and possible functions. Biochimie 74(3):217-223.
21. Murachi T, Takano E, Maki M, Adachi Y, Hatanaka M (1989): Cloning and expression of the genes for calpains and calpastatins. Biochem Soc Symp 55:29-44.
22. Murachi T (1989): Intracellular regulatory system involving calpain and calpastatin. Biochem Int 18(2):263-294.
23. Ohno S, Minoshima S, Kudoh J, Fukuyama R, Shimizu Y, Ohmi-Imajoh S, Shimizu N, Suzuki K (1990): Four genes for the calpain family locate on four distinct human chromosomes. Cytogenet Cell Gene 53(4):225-229.
24. Perlmutter LS, Gall C, Baudry M, Lynch G (1990): Distribution of calcium-activated protease calpain in the rat brain. J Comp Neuro 296:269-276.
25. Richard I, Broux O, Allamand V, Fougerousse F, Chiannilkulchai N, Bourg N, Brenguier L, Devaud C, Pasturaud P, Roudaut C (1995): Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 81(1):27-40.
26. Schlaepfer WW (1974): Calcium-induced degeneration of axoplasm in isolated segments of rat phrenic nerve. Brain Res 69:203-215.
27. Schlaepfer WW, Hasler MB (1979): Characterization of the calcium-induced disruption of neurofilaments in rat peripheral nerves. Brain Res 168:299-309.
28. Schlaepfer WW, Micko S (1979): Calcium-dependent alterations of neurofilament proteins of rat peripheral nerve. J Neurochem 32:211-219.
29. Schlaepfer WW, Zimmerman UP (1984): Calcium-activated protease and regulation of the axonal cytoskeleton. IN Elam JS, Cancalon P (eds): "Axonal transport in Neuronal Growth and Regeneration." New York: Plenum Press, pp 261-273.
30. Schlaepfer WW, Lee C, Lee VM-Y, Zimmerman U-JP (1985): An immunoblot study of neurofilament degradation in situ and during calcium-activated proteolysis. J Neurochem 44:502-509.
31. Smith DB, Johnson KS (1988): Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67:31-40.
32. Sorimachi H, Saido TC, Suzuki K (1994): New era of calpain research. Discovery of tissue-specific calpains. FEBS Lett 343(1): 1-5.
33. Sorimachi H, Ishiura S, Suzuki K (1993): A novel tissue-specific calpain species expressed predominantly in the stomach comprises two alternative splicing products with and without Ca(2+)-binding domain. J Biol Chem 268(26):19476-19482.
34. Sorimachi H, Imajoh-Ohmi S, Emori Y (1989): Molecular cloning of a novel mammalian calcium-dependent protease distinct from both m-and mu-types. Specific expression of the mRNA in skeletal muscle, J Biol Chem 264(33):20106-20111.
35. Sorimachi H, Kinbara K, Kimura S, Takahashi M, Ishiura S, Sasagawa N, Sorimachi N, Shimada H, Tagawa K, Maruyama K (1995): Muscle-specific calpain, p94, responsible for limb girdle muscular dystrophy type 2A, associates with connectin through IS2, a p94-specific sequence. J Biol Chem 270(52):31158-31162.
36. Spencer MJ, Croall DE, Tidball JG (1995): Calpains are activated in neurotic fibers from mdx dystrophic mice. J Biol Chem 270(18):10909-10914.
37. Suzuki K, Sorimachi H, Yoshizawa T, Kinbara K, Ishiura S (1995): Calpain: novel family members, activation, and physiologic function. Biol Chem Hoppe-Seyler 376(9):523-529.
38. Takeuchi KH, Saito KI, Nixon RA (1992): Immunoassay and activity of calcium-activated neutral proteinase (mCANP): distribution in soluble and membrane-associated fractions in human and mouse brain. J Neurochem 58(4): 1526-1532.